BLOG

Patent analysis and insight

Analysis and insight to bring more predictability, transparency, and equity to your patent prosecution.

Posts about

patent prosecution (4)

The Future of Pharma: The AstraZeneca / Gilead Merger

In early June, AstraZeneca approached rival drugmaker Gilead Sciences to discuss a potential.

Read More

Green Technology at the USPTO

On this year’s World IP Day, WIPO Director General Francis Gurry called for a surge in green.

Read More

Examiners Who Procrastinate the Most – And How They Can Help You Get Your Next Allowance

Procrastination. We all do it. In-house counsel do it, OCs do it, and USPTO examiners do it. In.

Read More

5 Things In-House Teams Can Do Right Now to Prepare for the Future

Now is not the time to be idle. There are plenty of steps in-house IP departments can take now.

Read More

USPTO Extends Deadlines Under CARES Act to June 1, 2020

The USPTO has announced that, in accordance with the CARES Act, it is further extending the.

Read More

The Sky Is Not Falling: COVID-19’s Impact on Patent Filing and Prosecution

Following industry news these days, it’s hard to avoid theories that the economic instability.

Read More

The CARES Act and the USPTO: Are Your Applications Eligible?

Prompted by the CARES Act, the USPTO announced extensions to the time allowed to file certain.

Read More

How to Use Prosecution Data to Quantify ROI to Clients

As businesses feel the stress from COVID-19, some are considering bringing patent prosecution.

Read More

How to Handle Office Actions More Efficiently

Even during these uncertain times, the USPTO maintains that operations will continue without.

Read More

The Future of Pharma: The AbbVie / Allergan Merger

Biopharmaceutical companies AbbVie Inc. and Allergan recently announced that they signed a.

Read More

Are you ready to transform your patent practice?

Patent prosecution is complex – we know. If you’re ready for simpler workflows and more predictable outcomes, give us a call.